Trials / Unknown
UnknownNCT03399344
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 270 (estimated)
- Sponsor
- The Netherlands Cancer Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The only chance of cure for patients with advanced stage ovarian cancer is complete cytoreductive surgery (CRS). The only way to determine whether complete CRS can be achieved is by a laparoscopy. However, diffusion-weighted magnetic resonance imaging (DW-MRI) has a very high sensitivity to detect small volume malignant disease, making it a potentially suitable staging tool. Aim of this study is to determine the performance of DW-MRI for predicting whether complete CRS can be achieved.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MRI | In addition to the standard diagnostic work-up patients will receive an additional MRI scan 0-21 days prior to their scheduled surgery. |
Timeline
- Start date
- 2018-04-13
- Primary completion
- 2022-04-01
- Completion
- 2022-07-01
- First posted
- 2018-01-16
- Last updated
- 2018-05-22
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03399344. Inclusion in this directory is not an endorsement.